Erythema multiforme after SARS-CoV-2 vaccine
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY（2022）
摘要
A 46-year-female presented with a one-week history of multiple erythema and blisters with pruritus on the extremities. She had received both doses of the SARS-CoV-2 vaccine (CoronaVac developed by Sinovac Life Sciences, Beijing, China) which is an inactivated vaccine. She had no adverse reactions after the first dose.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要